SCHEMBL21596788

SCHEMBL21596788

N#Cc1c(F)cc(OC(F)F)cc1F

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 1/20 0.48
▸ ADORA1 P30542 3/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ HSP90AA1 P07900 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ CCR6 P51684 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ EGLN2 Q96KS0 2/20 0.30
▸ EPAS1 Q99814 1/20 0.30
▸ VEGFA P15692 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21596828 0.84 TRPV4 (0.35) TRPV4ADORA1ADORA2AMEN1ALDH1A1
SCHEMBL24413387 0.76 TRPV4 (0.54) TRPV4EGLN2EPAS1VEGFA
SCHEMBL13863736 0.76 TRPV4 (0.54) TRPV4EGLN2EPAS1
SCHEMBL17365726 0.75 GRIN1 (0.34) MEN1ALDH1A1LMNAHSP90AA1PKM
SCHEMBL559898 0.75 TRPV4 (0.48) TRPV4LMNAHTT
SCHEMBL186585 0.74 TRPV4 (0.52) TRPV4ADORA1ADORA2AMEN1ALDH1A1
SCHEMBL29639661 0.72 EPAS1 (0.45) EPAS1VEGFA
SCHEMBL24816740 0.72 TRPV4 (0.41) TRPV4EGLN2
SCHEMBL18036193 0.72 EGLN2 (0.36) ADORA1ADORA2AEGLN2
SCHEMBL31535909 0.72 TRPV4 (0.37) TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 — — US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 — — US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 — — CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 — — EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 — — EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 — — EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 — — US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 — — US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 — — EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 — — US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 — — US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 — — WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 TRPV4 908/4885ADORA1 2465/4885ADORA2A 4338/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 TRPV4 909/4885ADORA1 2462/4885ADORA2A 4335/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B TRPV4 1449/4885ADORA1 622/4885ADORA2A 2191/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 TRPV4 909/4885ADORA1 2462/4885ADORA2A 4335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback